PortfoliosLab logoPortfoliosLab logo
XPH vs. GLD
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

XPH vs. GLD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in SPDR S&P Pharmaceuticals ETF (XPH) and SPDR Gold Shares (GLD). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, XPH achieves a 0.66% return, which is significantly lower than GLD's 2.92% return. Over the past 10 years, XPH has underperformed GLD with an annualized return of 3.44%, while GLD has yielded a comparatively higher 13.12% annualized return.


XPH

1D
1.10%
1M
-4.74%
YTD
0.66%
6M
4.44%
1Y
37.98%
3Y*
13.07%
5Y*
3.50%
10Y*
3.44%

GLD

1D
-0.99%
1M
-1.65%
YTD
2.92%
6M
5.43%
1Y
32.04%
3Y*
31.09%
5Y*
18.15%
10Y*
13.12%
*Multi-year figures are annualized to reflect compound growth (CAGR)

XPH vs. GLD - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
XPH
SPDR S&P Pharmaceuticals ETF
0.66%31.60%4.94%2.97%-9.83%-10.54%14.68%25.61%-15.32%12.05%
GLD
SPDR Gold Shares
2.92%63.68%26.66%12.69%-0.77%-4.15%24.81%17.86%-1.94%12.81%

Correlation

The correlation between XPH and GLD is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.15

Correlation (3Y)
Calculated over the trailing 3-year period

0.13

Correlation (5Y)
Calculated over the trailing 5-year period

0.11

Correlation (10Y)
Calculated over the trailing 10-year period

0.05

Correlation (All Time)
Calculated using the full available price history since Jun 23, 2006

0.03

The correlation between XPH and GLD shifts across timeframes, from 0.03 (all time) to 0.15 (1 year), reflecting how their relationship changes across market environments.

XPH vs. GLD - Sectors Allocation Comparison


Sectors
XPH
GLD

Healthcare

100.0%

-

Basic Materials

-

100.0%

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Financial Services

-

-

Industrials

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

XPH
100.0%
GLD

-

Basic Materials

XPH

-

GLD
100.0%

Communication Services

XPH

-

GLD

-

Consumer Cyclical

XPH

-

GLD

-

Consumer Defensive

XPH

-

GLD

-

Energy

XPH

-

GLD

-

Financial Services

XPH

-

GLD

-

Industrials

XPH

-

GLD

-

Real Estate

XPH

-

GLD

-

Technology

XPH

-

GLD

-

Utilities

XPH

-

GLD

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

XPH vs. GLD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

XPH
XPH Risk / Return Rank: 5555
Overall Rank
XPH Sharpe Ratio Rank: 5151
Sharpe Ratio Rank
XPH Sortino Ratio Rank: 5151
Sortino Ratio Rank
XPH Omega Ratio Rank: 4646
Omega Ratio Rank
XPH Calmar Ratio Rank: 6464
Calmar Ratio Rank
XPH Martin Ratio Rank: 6363
Martin Ratio Rank

GLD
GLD Risk / Return Rank: 3232
Overall Rank
GLD Sharpe Ratio Rank: 3232
Sharpe Ratio Rank
GLD Sortino Ratio Rank: 2929
Sortino Ratio Rank
GLD Omega Ratio Rank: 3535
Omega Ratio Rank
GLD Calmar Ratio Rank: 3333
Calmar Ratio Rank
GLD Martin Ratio Rank: 2828
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

XPH vs. GLD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for SPDR S&P Pharmaceuticals ETF (XPH) and SPDR Gold Shares (GLD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


XPHGLDDifference
Sharpe ratioReturn per unit of total volatility

+0.56

Sortino ratioReturn per unit of downside risk

+0.91

Omega ratioGain probability vs. loss probability

1.30

1.24

+0.05

Calmar ratioReturn relative to maximum drawdown

3.19

1.68

+1.51

Martin ratioReturn relative to average drawdown

11.37

4.15

+7.22

XPH vs. GLD - Sharpe Ratio Comparison

The current XPH Sharpe Ratio is 1.77, which is higher than the GLD Sharpe Ratio of 1.21. The chart below compares the historical Sharpe Ratios of XPH and GLD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


XPHGLDDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.77

1.21

+0.56

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.17

1.01

-0.85

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.16

0.83

-0.67

Sharpe Ratio (All Time)

Calculated using the full available price history

0.38

0.60

-0.22

Drawdowns

XPH vs. GLD - Drawdown Comparison

The maximum XPH drawdown since its inception was -48.03%, which is greater than GLD's maximum drawdown of -45.56%. Use the drawdown chart below to compare losses from any high point for XPH and GLD.


Loading charts...

Drawdown Indicators


XPHGLDDifference

Max Drawdown

Largest peak-to-trough decline

-48.03%

-45.56%

-2.47%

Max Drawdown (1Y)

Largest decline over 1 year

-11.97%

-19.21%

+7.24%

Max Drawdown (3Y)

Largest decline over 3 years

-23.57%

-19.21%

-4.36%

Max Drawdown (5Y)

Largest decline over 5 years

-31.63%

-21.03%

-10.60%

Max Drawdown (10Y)

Largest decline over 10 years

-35.97%

-22.00%

-13.97%

Current Drawdown

Current decline from peak

-7.22%

-17.75%

+10.53%

Average Drawdown

Average peak-to-trough decline

-17.25%

-16.16%

-1.09%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.35%

7.73%

-4.38%

Volatility

XPH vs. GLD - Volatility Comparison

SPDR S&P Pharmaceuticals ETF (XPH) has a higher volatility of 7.03% compared to SPDR Gold Shares (GLD) at 5.51%. This indicates that XPH's price experiences larger fluctuations and is considered to be riskier than GLD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


XPHGLDDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.03%

5.51%

+1.52%

Volatility (6M)

Calculated over the trailing 6-month period

16.77%

23.16%

-6.39%

Volatility (1Y)

Calculated over the trailing 1-year period

21.52%

26.61%

-5.09%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

20.84%

18.00%

+2.84%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

22.10%

15.95%

+6.15%

XPH vs. GLD - Expense Ratio Comparison

XPH has a 0.35% expense ratio, which is lower than GLD's 0.40% expense ratio.


Dividends

XPH vs. GLD - Dividend Comparison

XPH's dividend yield for the trailing twelve months is around 0.66%, while GLD has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
GLD
SPDR Gold Shares
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
XPH
SPDR S&P Pharmaceuticals ETF
0.66%0.83%1.58%1.28%1.64%0.95%0.47%0.64%0.65%0.67%0.63%7.15%

Frequently Asked Questions


XPH and GLD have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

XPH has higher volatility (7.03%) compared to GLD (5.51%). In terms of maximum drawdown, XPH dropped -48.03% vs GLD's -45.56%.

On 10-year performance, GLD leads with 13.12% vs 3.44% for XPH. On fees, XPH is cheaper at 0.35% per year. On volatility, GLD has been the lower-risk option at 5.51%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, GLD has performed better with a 13.12% return vs 3.44%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

XPH is cheaper with a 0.35% expense ratio, compared with 0.40% for GLD.

XPH has the higher dividend yield at 0.66%, compared with 0.00% for GLD.

XPH is categorized as Health & Biotech Equities, while GLD is Gold. XPH tracks S&P Pharmaceuticals Select Industry Index, while GLD tracks LBMA Gold Price PM. Their fees differ too: 0.35% for XPH and 0.40% for GLD.

XPH currently has the higher Sharpe Ratio (1.77 vs 1.21), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for XPH and GLD

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer